Additional file 1 of HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA

Additional file 1: Supplementary appendix. Includes Supplementary Table S1. Baseline demographic and disease characteristics by SE genotype (as-treated analysis population) and Supplementary Table S2. Clinical outcomes at Weeks 24 and 48 by SE genotype (as-treated analysis).